Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes | Synapse

June 29, 2020

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

European Foundation for the Study of Diabetes, supported by an unrestricted educational grant from AstraZeneca. (PROSPERO: CRD42019122043).

Preguntar a la IA

Me gusta

Guardar

Compartir

Cite This Study

Τσάπας et al. (Mon,) studied this question.

synapsesocial.com/papers/69df7d481113c054a47a167e https://doi.org/https://doi.org/10.7326/m20-0864

Preguntar a la IA

Me gusta

Guardar

Compartir

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The relation between treatment benefit and underlying risk in meta-analysis1996 · 171 citations
2Patients’ and Clinicians’ Preferences on Outcomes and Medication Attributes for Type 2 Diabetes: a Mixed-Methods Study2020 · 16 citations
3Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a<i>Diabetes Care</i>Editors’ Expert Forum2017 · 369 citations
4CINeMA: An approach for assessing confidence in the results of a network meta-analysis2020 · 1,734 citations
5Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials2019 · 1,623 citations